VALUE OF TRANSFUSION INDEPENDENCE IN SEVERE APLASTIC ANEMIA FROM PATIENTS’ PERSPECTIVES - A DISCRETE CHOICE EXPERIMENT
Author(s)
Pickard AS1, Huynh L2, Ivanova JI3, Totev T2, Graham S4, Mühlbacher AC5, Roy A6, Duh MS2
1Second City Outcomes Research, Oak Park, IL, USA, 2Analysis Group, Inc., Boston, MA, USA, 3Analysis Group, Inc., New York, NY, USA, 4Analysis Group, Inc., Menlo Park, CA, USA, 5Hochschule Neubrandenburg, Neubrandenburg, Germany, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
OBJECTIVES: Aplastic anemia is a rare (600-900 US cases/year), serious blood disorder due to bone marrow failure to produce blood cells. Transfusions are used to reduce risk of bleeding, infection and relieve anemia symptoms. In severe patients, transfusions may be required more than once/week. The study aimed to elicit patient preferences for attributes associated with severe aplastic anemia (SAA) treatment, including transfusion independence. METHODS: An online discrete choice experiment (DCE) was conducted among patients with SAA who experienced insufficient response to immunosuppressive therapy (IST) and transfusion dependence for ≥3 months in the past 2 years. Recruitment occurred through an International Foundation and clinical sites. The DCE elicited preferences between hypothetical treatment pairs characterized by a common set of attributes: transfusions frequency, fatigue, risk of infection, and risk of serious bleeding. Conditional logit model with effects coding was used to estimate part-worth utilities for different attribute levels and assess the relative importance of each attribute. Predicted utility scores for transfusion frequency levels were reported. RESULTS: Thirty patients completed the survey. Most were age ≥40 years (73%), female (70%), and from the US (87%). 33% underwent bone marrow transplant; 37% received iron chelation therapy. Patients largely agreed that transfusion independence would bring less burden on time and costs, greater control and quality of life, less fatigue (87% noted each) and less scheduling around medical appointments (83%). The DCE found highest relative importance for risk of bleeding (0.30), followed by risk of infection (0.28), fatigue (0.23), and frequency of transfusions (0.20). More frequent transfusions resulted in lower utility, particularly increasing monthly transfusions frequency from 4 (0.57) to 8 (0.35). CONCLUSIONS: Among SAA patients with insufficient response to IST, estimated utility was higher with fewer transfusions. While risk of bleeding, risk of infection, and fatigue were more important for patient treatment preferences, frequency of transfusions was also important.
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PSY88
Topic
Patient-Centered Research
Topic Subcategory
Stated Preference & Patient Satisfaction
Disease
Systemic Disorders/Conditions